{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:54:15Z","timestamp":1787997255878,"version":"build-2784847793"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Medical University of Lublin (Poland)","award":["DS 474\/2012-2015"],"award-info":[{"award-number":["DS 474\/2012-2015"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.eplepsyres.2018.06.003","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T19:39:19Z","timestamp":1529350759000},"page":"116-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Combination of phenobarbital with phenytoin and pregabalin produces synergy in the mouse tonic-clonic seizure model: An isobolographic analysis"],"prefix":"10.1016","volume":"145","author":[{"given":"Jarogniew J.","family":"Luszczki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lech P.","family":"Mazurkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Wroblewska-Luczka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Wlaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazyna","family":"Ossowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Szpringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Zolkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Florek-Luszczki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0005","series-title":"AVMA Guidelines for the Euthanasia of Animals: 2013 Edition","author":"AVMA","year":"2013"},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0010","first-page":"81","article-title":"Une nouvelle m\u00e9thode simple pour explorer l\u2019action \u00abtranquillisante\u00bb: le test de la chemin\u00e9e","volume":"3","author":"Boissier","year":"1960","journal-title":"in French) Pharmacology"},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/BF00500017","article-title":"Antiepileptic drug combinations and experimental background: the case of phenobarbital and phenytoin","volume":"333","author":"Bourgeois","year":"1986","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.seizure.2011.01.004","article-title":"Combining antiepileptic drugs\u2013rational polytherapy?","volume":"20","author":"Brodie","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1014233102342","article-title":"Ignoring pharmacokinetics may lead to isoboles misinterpretation: illustration with the norfloxacin-theophylline convulsant interaction in rats","volume":"19","author":"Cadart","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/2042098614560736","article-title":"New antiepileptic medication linked to blue discoloration of the skin and eyes","volume":"6","author":"Clark","year":"2015","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1568026053386962","article-title":"Mechanisms of action of antiepileptic drugs","volume":"5","author":"Czapinski","year":"2005","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0040","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/j.1528-1157.2000.tb00111.x","article-title":"Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed","volume":"41","author":"Deckers","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0045","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/fcp.12123","volume":"29","author":"Florek-Luszczki","year":"2015","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0050","article-title":"Vigabatrin: lessons learned from the United States experience","author":"Foroozan","year":"2017","journal-title":"J. Neuroophthalmol."},{"issue":"Suppl. (4)","key":"10.1016\/j.eplepsyres.2018.06.003_bib0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/epi.12294","article-title":"Development of new treatment approaches for epilepsy: unmet needs and opportunities","volume":"54","author":"French","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0060","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jamadermatol.2013.8895","article-title":"Blue-gray mucocutaneous discoloration: a new adverse effect of ezogabine","volume":"150","author":"Garin Shkolnik","year":"2014","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0065","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1046\/j.1528-1157.2002.00502.x","article-title":"Patients treated with vigabatrin exhibit central visual function loss","volume":"43","author":"Hilton","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0070","first-page":"195","article-title":"Anticonvulsant potency of 10 various p-isopropoxyphenylsuccinimide derivatives in the maximal electroshock-induced seizure threshold model in mice","volume":"11","author":"Kocharov","year":"2017","journal-title":"Health Prob. Civ."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0075","first-page":"55","article-title":"Interaction of three-drug combination of lacosamide, carbamazepine and phenobarbital in the mouse maximal electroshock-induced seizure model \u2013 an isobolographic analysis","volume":"10","author":"Kondrat-Wrobel","year":"2016","journal-title":"Health Prob. Civ."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.15584\/ejcem.2017.4.1","article-title":"Additive interaction for three-drug combination of carbamazepine, lacosamide and lamotrigine against maximal electroshock-induced seizures \u2013 a type I isobolographic analysis","volume":"15","author":"Kondrat-Wrobel","year":"2017","journal-title":"Eur J. Clin. Exp. Med."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0085","doi-asserted-by":"crossref","DOI":"10.17219\/acem\/69132","article-title":"Isobolographic additivity among lacosamide, lamotrigine and phenobarbital in the mouse tonic-clonic seizure model","volume":"27","author":"Kondrat-Wrobel","year":"2018","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0090","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2165\/00003495-200666140-00004","article-title":"Combination therapy in epilepsy: when and what to use","volume":"66","author":"Kwan","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0100","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","article-title":"Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs","volume":"20","author":"Loscher","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yebeh.2015.02.027","article-title":"Single versus combinatorial therapies in status epilepticus: novel data from preclinical models","volume":"49","author":"Loscher","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0920-1211(91)90075-Q","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models","volume":"8","author":"Loscher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0115","first-page":"31","article-title":"Additive interaction of pregabalin with phenytoin in the mouse maximal electroshock-induced seizure model: an isobolographic analysis","volume":"22","author":"Luszczki","year":"2009","journal-title":"Ann. UMCS Sectio DDD: Pharm."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0120","first-page":"103","article-title":"Interactions between pregabalin and phenobarbital in the mouse maximal electroshock-induced seizure model: an isobolographic analysis","volume":"3","author":"Luszczki","year":"2009","journal-title":"J. Pre-Clin. Clin. Res."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0125","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000444452","article-title":"Isobolographic analysis of interaction for three-drug combination of carbamazepine, phenobarbital and topiramate in the mouse maximal electroshock-induced seizure model","volume":"97","author":"Luszczki","year":"2016","journal-title":"Pharmacology"},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0130","first-page":"787","article-title":"2-Chloro-N6-cyclopentyladenosine enhances the anticonvulsant action of carbamazepine in the mouse maximal electroshock-induced seizure model","volume":"57","author":"Luszczki","year":"2005","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0135","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.yebeh.2005.07.007","article-title":"Pharmacodynamic and\/or pharmacokinetic characteristics of interactions between loreclezole and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis","volume":"7","author":"Luszczki","year":"2005","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2006.07.037","article-title":"Arachidonyl-2\u2019-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model","volume":"547","author":"Luszczki","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00210-006-0055-4","article-title":"Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"373","author":"Luszczki","year":"2006","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0150","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00702-008-0046-3","article-title":"Agmatine enhances the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock seizure model","volume":"115","author":"Luszczki","year":"2008","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0155","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.eplepsyres.2010.01.001","article-title":"Interactions of 1-methyl-1,2,3,4-tetrahydroisoquinoline with lamotrigine, oxcarbazepine, pregabalin, and topiramate in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis","volume":"89","author":"Luszczki","year":"2010","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pnpbp.2009.09.005","article-title":"Effect of arachidonyl-2\u2019-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the protective action of the various antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"34","author":"Luszczki","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0165","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejphar.2013.10.020","article-title":"Effects of WIN 55,212-2 mesylate on the anticonvulsant action of lamotrigine, oxcarbazepine, pregabalin and topiramate against maximal electroshock-induced seizures in mice","volume":"720","author":"Luszczki","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183873","article-title":"Effects of arachidonyl-2\u2019-chloroethylamide (ACEA) on the protective action of various antiepileptic drugs in the 6-Hz corneal stimulation model in mice","volume":"12","author":"Luszczki","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0175","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1474-4422(10)70059-4","article-title":"Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders","volume":"9","author":"Mantegazza","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0180","first-page":"233","article-title":"A method for the routine assessment of fore- and hindlimb grip strength of rats and mice","volume":"1","author":"Meyer","year":"1979","journal-title":"Neurobehav. Toxicol."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0185","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(03)00409-5","article-title":"Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs","volume":"2","author":"Patsalos","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0190","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1474-4422(03)00483-6","article-title":"Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs","volume":"2","author":"Patsalos","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0195","first-page":"31","article-title":"Pharmacological principles as a basis for polytherapy","volume":"162","author":"Perucca","year":"1995","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0200","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11910-008-0053-7","article-title":"New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7\/KCNQ\/M potassium channels","volume":"8","author":"Rogawski","year":"2008","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0205","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/seiz.2002.0711","article-title":"Seizure freedom with more than one antiepileptic drug","volume":"11","author":"Stephen","year":"2002","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0210","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/WCO.0b013e328350ba68","article-title":"Antiepileptic drug monotherapy versus polytherapy: pursuing seizure freedom and tolerability in adults","volume":"25","author":"Stephen","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0215","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.eplepsyres.2011.09.008","article-title":"Antiepileptic drug combinations--have newer agents altered clinical outcomes?","volume":"98","author":"Stephen","year":"2012","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0220","series-title":"Drug Synergism and Dose-Effect Data Analysis","author":"Tallarida","year":"2000"},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0225","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/1947601912440575","article-title":"Quantitative methods for assessing drug synergism","volume":"2","author":"Tallarida","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0230","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.112.193474","article-title":"Revisiting the isobole and related quantitative methods for assessing drug synergism","volume":"342","author":"Tallarida","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0235","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/321864a0","article-title":"Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks","volume":"321","author":"Venault","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0240","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1684\/epd.2014.0714","article-title":"Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs","volume":"16","author":"Zaccara","year":"2014","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0245","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S1734-1140(09)70128-8","article-title":"Characterization of acute adverse-effect profiles of selected antiepileptic drugs in the grip-strength test in mice","volume":"61","author":"Zadrozniak","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.eplepsyres.2018.06.003_bib0250","first-page":"54","article-title":"Isobolographic assessment of interactions between retigabine and phenytoin in the mouse maximal electroshock-induced seizure model and chimney test","volume":"10","author":"Zolkowska","year":"2016","journal-title":"Health Prob. Civ."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121118300056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121118300056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:40:13Z","timestamp":1760276413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121118300056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":50,"alternative-id":["S0920121118300056"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.06.003","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of phenobarbital with phenytoin and pregabalin produces synergy in the mouse tonic-clonic seizure model: An isobolographic analysis","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}